Login / Signup

Biosynthesis of Conjugate Vaccines Using an O-Linked Glycosylation System.

Chao PanPeng SunBo LiuHaoyu LiangZhehui PengYan DongDongshu WangXiankai LiuBin WangMing ZengJun WuLi ZhuHengliang Wang
Published in: mBio (2016)
Recently, the rapid development of synthetic biology has allowed bioconjugate vaccines with N-linked protein glycosylation to become a reality. However, the difficulty of reestablishing the exogenous polysaccharide synthetic pathway in Escherichia coli hinders their application. Here, we show that an O-linked protein glycosylation system from Neisseria meningitidis, which has a lower structure specificity for sugar substrates, could be engineered directly in attenuated pathogens to produce effective conjugate vaccines. To facilitate the further design of next-generation bioconjugate vaccines, we optimized a novel short motif consisting of 8 amino acids that is sufficient for glycosylation. Our results expand the application potential of O-linked protein glycosylation and demonstrate a simpler and more robust strategy for producing bioconjugate vaccines against different pathogens. In the future, bacterial antigenic polysaccharides could be attached to major histocompatibility complex binding peptides to improve immunological memory or attached to protein subunit vaccine candidates to provide double immune stimulation.
Keyphrases
  • amino acid
  • escherichia coli
  • protein protein
  • binding protein
  • cancer therapy
  • gram negative
  • transcription factor
  • pseudomonas aeruginosa
  • climate change
  • multidrug resistant
  • candida albicans